Free Trial

Polyrizon (PLRZ) Competitors

Polyrizon logo
$1.02 -0.05 (-4.67%)
As of 09/5/2025 04:00 PM Eastern

PLRZ vs. FBLG, ENLV, RLYB, AKTX, THAR, ALVR, NAII, PASG, PMN, and NNVC

Should you be buying Polyrizon stock or one of its competitors? The main competitors of Polyrizon include FibroBiologics (FBLG), Enlivex Therapeutics (ENLV), Rallybio (RLYB), Akari Therapeutics (AKTX), Tharimmune (THAR), AlloVir (ALVR), Natural Alternatives International (NAII), Passage Bio (PASG), Promis Neurosciences (PMN), and NanoViricides (NNVC). These companies are all part of the "pharmaceutical products" industry.

Polyrizon vs. Its Competitors

Polyrizon (NASDAQ:PLRZ) and FibroBiologics (NASDAQ:FBLG) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

Polyrizon's return on equity of 0.00% beat FibroBiologics' return on equity.

Company Net Margins Return on Equity Return on Assets
PolyrizonN/A N/A N/A
FibroBiologics N/A -710.25%-118.02%

FibroBiologics has a consensus target price of $13.00, suggesting a potential upside of 2,163.63%. Given FibroBiologics' stronger consensus rating and higher possible upside, analysts clearly believe FibroBiologics is more favorable than Polyrizon.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Polyrizon
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
FibroBiologics
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Polyrizon and Polyrizon both had 1 articles in the media. Polyrizon's average media sentiment score of 0.00 equaled FibroBiologics'average media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Polyrizon
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
FibroBiologics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PolyrizonN/AN/A-$1.54MN/AN/A
FibroBiologicsN/AN/A-$11.16M-$0.36-1.60

Summary

Polyrizon and FibroBiologics tied by winning 3 of the 6 factors compared between the two stocks.

Get Polyrizon News Delivered to You Automatically

Sign up to receive the latest news and ratings for PLRZ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PLRZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PLRZ vs. The Competition

MetricPolyrizonMED IndustryMedical SectorNASDAQ Exchange
Market Cap$6.11M$3.18B$5.83B$9.93B
Dividend YieldN/A2.27%6.70%4.52%
P/E RatioN/A21.1076.1526.11
Price / SalesN/A466.44562.61123.62
Price / CashN/A45.7236.9959.28
Price / Book0.009.8711.486.09
Net Income-$1.54M-$53.42M$3.29B$266.51M
7 Day Performance-6.42%2.93%1.27%0.46%
1 Month Performance-11.30%9.85%7.94%4.59%
1 Year PerformanceN/A15.74%62.94%26.04%

Polyrizon Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PLRZ
Polyrizon
N/A$1.02
-4.7%
N/AN/A$6.11MN/A0.00N/ANews Coverage
Gap Down
FBLG
FibroBiologics
2.262 of 5 stars
$0.60
-0.3%
$13.00
+2,063.1%
-69.1%$25.18MN/A-1.6710Gap Up
ENLV
Enlivex Therapeutics
3.5125 of 5 stars
$1.04
-1.9%
$10.00
+861.5%
-13.8%$24.60MN/A-1.5870News Coverage
Analyst Forecast
Short Interest ↓
Analyst Revision
RLYB
Rallybio
2.9842 of 5 stars
$0.59
+1.6%
$5.00
+751.8%
-45.2%$24.53M$640K-0.6240Short Interest ↓
Gap Up
AKTX
Akari Therapeutics
3.0808 of 5 stars
$0.74
+13.0%
$5.00
+575.7%
-76.5%$23.81MN/A0.009News Coverage
Short Interest ↑
Gap Up
THAR
Tharimmune
2.7956 of 5 stars
$4.05
-15.1%
$17.00
+319.8%
+26.9%$23.18MN/A-0.672News Coverage
Short Interest ↑
Gap Up
ALVR
AlloVir
N/A$4.57
+14.3%
N/A-73.4%$23.05MN/A-0.23110Gap Down
High Trading Volume
NAII
Natural Alternatives International
N/A$3.73
+2.7%
N/A-47.4%$23.05M$113.80M-2.68290Positive News
PASG
Passage Bio
3.4777 of 5 stars
$7.13
0.0%
$75.67
+961.7%
-44.4%$22.40MN/A-0.39130Positive News
Analyst Upgrade
PMN
Promis Neurosciences
2.8402 of 5 stars
$0.43
-5.8%
$4.33
+905.4%
-68.6%$22.33MN/A-2.055Gap Down
NNVC
NanoViricides
0.7338 of 5 stars
$1.39
-3.1%
N/A-16.3%$22.26MN/A-1.9220Positive News
Short Interest ↓

Related Companies and Tools


This page (NASDAQ:PLRZ) was last updated on 9/6/2025 by MarketBeat.com Staff
From Our Partners